1. Home
  2. UMBF vs ARWR Comparison

UMBF vs ARWR Comparison

Compare UMBF & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo UMB Financial Corporation

UMBF

UMB Financial Corporation

HOLD

Current Price

$119.24

Market Cap

8.2B

Sector

Finance

ML Signal

HOLD

Logo Arrowhead Pharmaceuticals Inc.

ARWR

Arrowhead Pharmaceuticals Inc.

HOLD

Current Price

$68.47

Market Cap

9.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UMBF
ARWR
Founded
1913
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.2B
9.6B
IPO Year
N/A
1993

Fundamental Metrics

Financial Performance
Metric
UMBF
ARWR
Price
$119.24
$68.47
Analyst Decision
Buy
Strong Buy
Analyst Count
11
10
Target Price
$136.27
$60.70
AVG Volume (30 Days)
436.7K
3.3M
Earning Date
01-27-2026
11-25-2025
Dividend Yield
1.46%
N/A
EPS Growth
10.98
N/A
EPS
8.89
N/A
Revenue
$2,217,071,000.00
$829,448,000.00
Revenue This Year
$69.52
N/A
Revenue Next Year
$7.83
N/A
P/E Ratio
$13.29
N/A
Revenue Growth
45.52
23258.15
52 Week Low
$82.00
$9.57
52 Week High
$126.14
$72.36

Technical Indicators

Market Signals
Indicator
UMBF
ARWR
Relative Strength Index (RSI) 65.02 72.80
Support Level $117.05 $68.01
Resistance Level $120.58 $72.36
Average True Range (ATR) 2.93 4.99
MACD 0.93 1.03
Stochastic Oscillator 87.52 86.66

Price Performance

Historical Comparison
UMBF
ARWR

About UMBF UMB Financial Corporation

UMB Financial Corp, or UMBF, is a financial services holding company offering a suite of banking services and asset servicing to its customers in the United States and around the world. Its client base includes commercial, institutional, and personal customers. Along with its subsidiaries, the company operates in the following business segments: Commercial Banking, Institutional Banking, and Personal Banking. A majority of its revenue is generated from the Commercial Banking segment, which serves the commercial banking and treasury management needs of small to middle-market businesses through various products and services such as commercial loans, commercial real estate financing, commercial credit cards, letters of credit, loan syndication services, consultative services, and others.

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.

Share on Social Networks: